United States. Securities and Exchange Commission
La Jolla Pharmaceutical Co Submits SEC Filing
A recent SEC filing by La Jolla Pharmaceutical Co has highlighted the company's biopharmaceutical activities. The document, filed on June 17, 2022, reveals the company's focus on biological products and diagnostic substances. According to the filing, the company is committed to transparency and compliance with SEC